Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2000
06/13/2000US6074643 Site-directed chemotherapy of metastases
06/13/2000US6074642 Reduce cell lysing ability of biological complement present in blood
06/13/2000US6074639 Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins
06/13/2000US6074637 Modifying cells by transfection with dna
06/13/2000US6074636 Method of using cell surface receptor targeted molecules for the treatment of viral diseases
06/13/2000US6074635 T cell activation
06/13/2000CA2159079C Methods and dna expression systems for over-expression of proteins in host cells
06/13/2000CA2157196C Inhibitors of herpes viral ribonucleotide reductase
06/13/2000CA2149038C Phospholipase c-inhibiting peptides
06/13/2000CA2137072C Conformationally restrained peptide analogs as antiplatelet agents
06/13/2000CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
06/13/2000CA2079105C Hepatitis c virus protease
06/13/2000CA2077537C Therapeutically useful peptides and peptide fragments
06/13/2000CA2048450C Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
06/13/2000CA2036398C Hiv protease inhibiting agents
06/13/2000CA2019006C Antiherpes tetrapeptide derivatives having a cycloalkyl substituted aspartic acid side chain
06/13/2000CA2014847C Process for the preparation of an antimicrobial particulate product, antimicrobial product thus obtained and its use
06/13/2000CA2003981C Pharmaceutical compositions and use thereof in the treatment of psoriasis
06/13/2000CA1341026C Il-1 inhibitors process for producing il-1 inhibitors and for using such inhibitors in therapy
06/13/2000CA1341023C Peptide derivatives
06/13/2000CA1341022C Prepro-lhrh c-terminal peptide
06/11/2000CA2255477A1 Human vitreous and pharmaceutical compositions
06/09/2000WO2000020019A3 A composition for the prevention and/or treatment of atherosclerosis
06/09/2000CA2290711A1 Methods for diagnosing a form of ataxia and compounds for use in the method
06/08/2000WO2000033068A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
06/08/2000WO2000032825A2 Development of anti-microbial agents based on bacteriophage genomics
06/08/2000WO2000032818A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression
06/08/2000WO2000032817A1 Antisense modulation of g-alpha-16 expression
06/08/2000WO2000032816A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000WO2000032803A2 Novel nucleic acid transferring agents, compositions containing them and uses
06/08/2000WO2000032787A1 Therapeutic agents comprising an e3 ubiquitin ligase for use in degenerative disorders
06/08/2000WO2000032784A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032778A2 Methods and compositions for inhibiting neoplastic cell growth
06/08/2000WO2000032776A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
06/08/2000WO2000032775A1 Pth1r and pth3r receptors
06/08/2000WO2000032774A1 12216 receptor, a g-protein coupled receptor
06/08/2000WO2000032772A2 Erythropoietic compounds
06/08/2000WO2000032771A1 Pth1r and pth3r receptors, methods and uses thereof
06/08/2000WO2000032770A1 Novel tumor antigen protein art-1 and tumor antigen peptide thereof
06/08/2000WO2000032769A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
06/08/2000WO2000032768A1 Polypeptides capable of interacting with the human topoisomerase iii alpha
06/08/2000WO2000032767A1 RECOMBINANT SOLUBLE Fc RECEPTORS
06/08/2000WO2000032765A2 Ribozyme therapy for the treatment and/or prevention of restenosis
06/08/2000WO2000032764A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000WO2000032759A1 Human plasminogen activator
06/08/2000WO2000032752A1 Psca: prostate stem cell antigen and uses thereof
06/08/2000WO2000032750A1 Transgenic circulating endothelial cells
06/08/2000WO2000032749A2 Methods and articles for regenerating living tissue
06/08/2000WO2000032746A2 Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
06/08/2000WO2000032745A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000WO2000032632A2 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use
06/08/2000WO2000032631A2 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof
06/08/2000WO2000032629A2 Antiviral peptides
06/08/2000WO2000032628A1 ReL1A BINDING INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
06/08/2000WO2000032620A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000WO2000032619A1 Methods and compositions for identification of inhibitors of ribosome assembly
06/08/2000WO2000032387A1 Interferon-alpha mediated upregulation of aquaporin expression
06/08/2000WO2000032251A1 Porous composite matrix and the production and use thereof
06/08/2000WO2000032237A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide
06/08/2000WO2000032235A1 Transport system conjugate
06/08/2000WO2000032233A2 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
06/08/2000WO2000032231A1 Stimulation of t cells against self antigens using ctla-4 blocking agents
06/08/2000WO2000032225A1 Tissue repair
06/08/2000WO2000032224A2 Calcitonin for the modulation of sperm function
06/08/2000WO2000032223A2 Therapeutic treatment with immunogenic drugs
06/08/2000WO2000032222A1 Improvement of folliculogenesis
06/08/2000WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000WO2000032220A1 Anti-dandruff composition comprising an antifungal polypeptide
06/08/2000WO2000032219A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier
06/08/2000WO2000032218A1 Controlled release formulation comprising gnrh-ii
06/08/2000WO2000032217A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
06/08/2000WO2000032215A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
06/08/2000WO2000032207A1 Spray delivery of cells
06/08/2000WO2000032172A1 An oral formulation for gastrointestinal drug delivery
06/08/2000WO2000032168A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases
06/08/2000WO2000032152A2 Compositions and methods for regulating bacterial pathogenesis
06/08/2000WO2000032039A1 PURIFIED AND ISOLATED piwi FAMILY GENES AND GENE PRODUCTS AND METHODS EMPLOYING SAME
06/08/2000WO2000017228A3 Stereoselective process for enalapril
06/08/2000WO2000015659A3 Stomach polypeptide zsig28
06/08/2000WO2000015245A3 Stable liquid formulations of botulinum toxin
06/08/2000WO2000014117A9 Peptide ligands for affinity purification of human factor viii
06/08/2000WO2000012541A3 Cytotoxic peptides modified by bulky or lipophilic moieties
06/08/2000WO2000012535A3 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
06/08/2000WO2000011191A3 Tpl-2/cot kinase and methods of use
06/08/2000WO2000010592A3 Medicaments for preventing or reducing scarring
06/08/2000WO2000010580A3 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders
06/08/2000WO2000009676A3 Methods of forming neurons
06/08/2000WO2000009086A3 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
06/08/2000WO2000007629A3 Peg-urate oxidase conjugates and use thereof
06/08/2000WO2000004137A9 Human aspartic proteases
06/08/2000WO1999064572A3 Poly(adp-ribose) polymerase gene
06/08/2000WO1999043803A9 Genomic gene encoding hm1.24 antigen protein and promoter thereof
06/08/2000WO1999024076A9 Salicylate derivatized therapeutic and diagnostic agents
06/08/2000DE19959689A1 Liposome composition for tumor, especially breast cancer, therapy comprises an alkyl phospholipid with antineoplastic activity and one or more antiestrogens
06/08/2000DE19855890A1 Poröse Kompositmatrix, deren Herstellung und Verwendung Porous composite matrix, their preparation and use
06/08/2000DE19855566A1 Use of a medicament comprising e.g. heparinoids for treating toothache and dental inflammation and suppuration by application to the skin
06/08/2000CA2503475A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2354187A1 Calcitonin for the modulation of sperm function
06/08/2000CA2353798A1 Controlled release formulation comprising gnrh-ii
1 ... 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 ... 3163